Ocular Therapeutix (OCUL)
10.64
0.00 (0.00%)
Upcoming Events
Latest Headlines
Form 4 OCULAR THERAPEUTIX, INC For: Aug 24 Filed by: Kaiser Peter
August 26, 2026 6:00 PM - SEC Filing
Form 4 OCULAR THERAPEUTIX, INC For: Aug 24 Filed by: Nayak Sanjay
August 26, 2026 5:58 PM - SEC Filing
Form 4 OCULAR THERAPEUTIX, INC For: Aug 24 Filed by: Heier Jeffrey S.
August 26, 2026 5:57 PM - SEC Filing
Form 4 OCULAR THERAPEUTIX, INC For: Aug 24 Filed by: Dugel Pravin
August 26, 2026 5:56 PM - SEC Filing
Form 144 OCULAR THERAPEUTIX, INC Filed by: Nayak Sanjay
August 24, 2026 4:46 PM - SEC Filing
Form 144 OCULAR THERAPEUTIX, INC Filed by: Dugel Pravin
August 24, 2026 4:45 PM - SEC Filing
Form 144 OCULAR THERAPEUTIX, INC Filed by: Heier Jeffrey S.
August 24, 2026 4:44 PM - SEC Filing
Form 144 OCULAR THERAPEUTIX, INC Filed by: Kaiser Peter
August 24, 2026 4:43 PM - SEC Filing
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 13, 2026 4:05 PM - Globe NewsWire
Increasing unusual put volume: OCUL IRM ALOY DFTX WY CIA ATAI WGMI ROST SLS EQX CRWG MUU CAVA BURL D NBIG ZSL
August 12, 2026 10:09 AM - StreetInsider
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 7, 2026 4:05 PM - Globe NewsWire
Form S-8 OCULAR THERAPEUTIX, INC
August 3, 2026 7:59 AM - SEC Filing
Ocular Therapeutix (OCUL) Tops Q2 EPS by 3c
August 3, 2026 7:19 AM - StreetInsider
Form 10-Q OCULAR THERAPEUTIX, INC For: Jun 30
August 3, 2026 7:17 AM - SEC Filing
Form 8-K OCULAR THERAPEUTIX, INC For: Aug 03
August 3, 2026 7:08 AM - SEC Filing
Ocular Therapeutix™ Reports Second Quarter 2026 Financial Results and Business Highlights
August 3, 2026 7:00 AM - Globe NewsWire
Form SCHEDULE 13G/A OCULAR THERAPEUTIX, INC Filed by: BlackRock, Inc.
July 29, 2026 3:21 PM - SEC Filing
Ocular Therapeutix (OCUL) Reiterated at Market Outperform by Citizens Ahead of Q2 Earnings
July 17, 2026 5:17 AM - StreetInsider
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 9, 2026 4:05 PM - Globe NewsWire
Ocular Therapeutix™ to Participate in July Scientific and Investor Conferences
July 1, 2026 7:00 AM - Globe NewsWire
William Blair Adjusts Monthly Analyst Conviction List for July 2026
July 1, 2026 6:19 AM - StreetInsider
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 22, 2026 4:05 PM - Globe NewsWire
Ocular Therapeutix (OCUL) PT Raised to $25 at H.C. Wainwright
June 22, 2026 6:59 AM - StreetInsider
Form 4 OCULAR THERAPEUTIX, INC For: Jun 16 Filed by: Dugel Pravin
June 18, 2026 4:01 PM - SEC Filing
Ocular Therapeutix (OCUL) PT Raised to $30 at Baird
June 18, 2026 6:14 AM - StreetInsider
Ocular Therapeutix plans wet AMD drug filing for late 2026
June 17, 2026 8:45 AM - StreetInsider
Ocular Therapeutix™ Investor Day to Highlight U.S. FDA Alignment on AXPAXLI™ NDA with Submission Planned for Fourth Quarter 2026
June 17, 2026 8:45 AM - Globe NewsWire
Ocular Therapeutix (OCUL) Halted, News Pending
June 17, 2026 8:41 AM - StreetInsider
Form 4 OCULAR THERAPEUTIX, INC For: Jun 10 Filed by: Warden Charles M
June 12, 2026 5:23 PM - SEC Filing
Form 4 OCULAR THERAPEUTIX, INC For: Jun 10 Filed by: Graves Adrienne L
June 12, 2026 5:23 PM - SEC Filing
Form 4 OCULAR THERAPEUTIX, INC For: Jun 10 Filed by: Robins Jason Shand
June 12, 2026 5:22 PM - SEC Filing
Form 4 OCULAR THERAPEUTIX, INC For: Jun 10 Filed by: Hong Seung Suh
June 12, 2026 5:21 PM - SEC Filing
Form 4 OCULAR THERAPEUTIX, INC For: Jun 10 Filed by: LINDSTROM RICHARD L MD
June 12, 2026 5:21 PM - SEC Filing
Form 4 OCULAR THERAPEUTIX, INC For: Jun 10 Filed by: RAINES MERILEE
June 12, 2026 5:20 PM - SEC Filing
Form 4 OCULAR THERAPEUTIX, INC For: Jun 10 Filed by: Williams Leslie J.
June 12, 2026 5:19 PM - SEC Filing
Form 8-K OCULAR THERAPEUTIX, INC For: Jun 10
June 12, 2026 4:23 PM - SEC Filing
Full Article List
